Atlas Trials

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer

Clinical trial NCT00171847 · TERMINATED

Trial details

NCT number
NCT00171847
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2003-03-01
Primary completion
2008-10-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.